[Federal Register Volume 65, Number 194 (Thursday, October 5, 2000)]
[Notices]
[Page 59453]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25543]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institutes of Health, National Cancer Institute; Notice 
of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the Advisory Committee to the Director, National Cancer Institute.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National 
Cancer Institute.
    Date: November 6, 2000.
    Time: 9:30 AM to 11:00 PM.
    Agenda: The purpose of this meeting will be to discuss the Brain 
Tumor Progress Review Group Report.
    Place: National Institutes of Health, 9000 Rockville Pike, 
Building 31, Room 11A10, Bethesda, MD 20892, (Telephone Conference 
Call).
    Contact Person: Susan J. Waldrop, Executive Secretary, National 
Institutes of Health, National Cancer Institute, Office of Science 
Policy, Bethesda, MD 20892, 301/496-1458.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 27, 2000.
LaVerne Y. Stringfield
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-25543 Filed 10-4-00; 8:45 am]
BILLING CODE 4140-01-M